PluriStem

Active Ingredient(s): Daniplestim
Category: Cancer



PluriStem Overview

Pluristem Therapeutics is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment.[3] According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.[4] Contents 1 Corporate history 2 Products 3 Human applications 4 See also 5 References 6 External links Corporate history Pluristem was founded in 2001 by Shai Meretzki of the Technion, who made...

Read more PluriStem Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pluristem_Therapeutics

Recent PluriStem Forums:

Be the first to start a discussion about this drug.

Other drugs which contain Daniplestim or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 March 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA